Legacy systems attempting to handle DRPs have been around for over 20 years.
But in reality, these systems only exacerbate and perpetuate the problem, as more than 98% of critical DRPs are ignored or overlooked by clinicians.
Because legacy systems generate:
Legacy systems generate ‘generic’ outputs, based on the general population, not even considering well-based research. They cannot differentiate between patients that are actually at risk for developing adverse effects, and those who are not. This causes legacy systems to:
A. Generate many non-relevant interruptive alerts, referred to as ‘false positives’
B. Create an intolerable alert-load, causing ‘alert fatigue’
Legacy systems don’t incorporate significant parameters that bear substantial impact on DRPs, such as genetic profile, laboratory results, ECG recordings, mechanism-based inference, and many others. This translates into low NPVs, meaning that legacy systems often don’t provide alert when they should be alerting.
Legacy system outputs are presented in cumbersome textual messages, forcing clinicians to spend excess time trying to understand the alerts, or simply ignoring and overriding
It’s our professional understanding and perception that Seegnal tackles extremely well all the weaknesses of current-available Drug interaction solutions, in a unique and exclusive manner and unlike any other solution that we are aware of.
John Horn, PharmD
Philip Hansten, PharmD
Seegnal is a smart clinical decision support platform that is patient-specific, comprehensive, accurate (about 98% PPV and NPV), and easy to use.